FDA Releases Revised Guidance on Reducing Zika Virus Risk in Blood and Blood Components

Summary

The Food and Drug Administration (FDA) has released revised guidance to reduce the risk of Zika virus transmission through blood and blood components. The guidance, which supersedes previous documents, provides recommendations for blood establishments to minimize the risk of ZIKV transmission.